• Home
  • The MMS Difference
    • About Us
    • Leadership
    • Certifications
  • Services
    • Regulatory Affairs and Operations
    • Data Management and Biostatistics
    • Regulatory and Medical Writing
    • Drug Safety and Pharmacovigilance
    • Compliance and Transparency
    • Data Sciences
  • Working with MMS
  • News and Media
  • MMS Blog
  • Careers
  • Contact Us
MMS
PhUSE: Retrospective vs. Proactive Anonymization of Narratives

PhUSE: Retrospective vs. Proactive Anonymization of Narratives

by Don McLean | Mar 14, 2019 | Blog

PhUSE: Retrospective vs. Proactive Anonymization of Narratives Exerpt from whitepaper originally published by PhUSE on March 14, 2019 by project co-leads – Rashmi Dodia, MS, RAC and Gregory Campbell, BS Executive Summary Ever since policy 0070 was first introduced in...
Safety Writing, REMS, and Regulatory Requirements: A Conversation with Jeffrey Wiese

Safety Writing, REMS, and Regulatory Requirements: A Conversation with Jeffrey Wiese

by Don McLean | Feb 7, 2019 | Blog

Safety Writing, REMS, and Regulatory Requirements: A Conversation with Jeffrey Wiese by Staff writer In this Expert Insights interview, we sit down with Jeffrey Wiese, Senior Safety Writer at MMS – to discuss safety writing in the pharmaceutical industry,...

Recent Posts

  • Dr. Mike Poole Joins the Board of Scientific Advisors at Top Global CRO MMS Holdings
  • Part 2: 505(b)(2) NDA – The Importance Early-Stage Planning
  • Part 1: 505(b)(2) NDA – Navigating the Regulatory Pathway
  • FREE DOWNLOAD: Lay Summary Whitepaper
  • MMS Holdings Leverages Medrio to Accelerate Clinical Trial Process for Study Sponsors Through New Contract

Tags

ALZ awareness Alzheimers big data biosimilars biostatistics Clinical Development clinical research clinical study reports clinical trials clinical trial transparency Community Compliance CRO data management data privacy data science drug development EMA ENDALZ FDA Flint GDPR GXP auditing Lay summaries leadership medical writing NDA submission opioids pharma pharmacovigilance PhUSE Policy 0070 quality control real world data regulatory operations REMS resourcing statistical programming suicidality transparency trial regulation Volunteering